Choosing Second-Line Therapy for Metastatic Kidney Cancer: Case 1
EP. 1: Case Details and Initial Impressions
February 16th 2017
EP. 2: Defining Recurrence in Metastatic RCC
February 16th 2017
EP. 3: Second-line Treatment Options for mRCC
February 16th 2017
EP. 4: The Rationale for Cabozantinib After Progression of mRCC
February 16th 2017
EP. 5: Experience with Cabozantinib in mRCC
February 16th 2017
EP. 6: Toxicities with Second-Line Therapy for mRCC
February 16th 2017
EP. 7: Toxicity Management for Cabozantinib
February 16th 2017
EP. 8: Upfront Cabozantinib vs Sunitinib in mRCC
February 16th 2017
